These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25456579)

  • 1. Does ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance.
    Mert KU; Mert GÖ; Başaran O; Biteker M
    Int J Cardiol; 2014 Dec; 177(2):726. PubMed ID: 25456579
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to letter: "Does Ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance".
    Gallet R; Ternacle J; Lim P
    Int J Cardiol; 2015 Jan; 179():217. PubMed ID: 25464449
    [No Abstract]   [Full Text] [Related]  

  • 3. Ivabradine: a promising drug in cardiogenic shock to prevent the undesirable sinus tachycardia induced by dobutamine?
    Lattuca B; Roubille F
    Int J Cardiol; 2015 Jan; 178():308-10. PubMed ID: 25305680
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction.
    Gallet R; Ternacle J; Damy T; Guendouz S; Bremont C; Seemann A; Gueret P; Dubois-Rande JL; Lim P
    Int J Cardiol; 2014 Sep; 176(2):450-5. PubMed ID: 25129291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.
    Link A; Reil JC; Selejan S; Böhm M
    Clin Res Cardiol; 2009 Aug; 98(8):513-5. PubMed ID: 19547907
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic response during low-dose dobutamine infusion in patients with chronic systolic heart failure: comparison of echocardiographic and invasive measurements.
    Egstrup M; Gustafsson I; Andersen MJ; Kistorp CN; Schou M; Tuxen CD; Møller JE
    Eur Heart J Cardiovasc Imaging; 2013 Jul; 14(7):659-67. PubMed ID: 23136446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).
    Borer JS; Böhm M; Ford I; Robertson M; Komajda M; Tavazzi L; Swedberg K;
    Am J Cardiol; 2014 Feb; 113(3):497-503. PubMed ID: 24332674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine for systolic heart failure.
    Meade CM; Clements JN
    JAAPA; 2018 Mar; 31(3):52-54. PubMed ID: 29470374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
    J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
    Udelson JE; Orlandi C; Ouyang J; Krasa H; Zimmer CA; Frivold G; Haught WH; Meymandi S; Macarie C; Raef D; Wedge P; Konstam MA; Gheorghiade M
    J Am Coll Cardiol; 2008 Nov; 52(19):1540-5. PubMed ID: 19007589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure and COPD: time to SHIFT?
    Sanders-van Wijk S; van Empel V; Knackstedt C; Brunner-La Rocca HP
    Int J Cardiol; 2014 Mar; 172(2):293-4. PubMed ID: 24452222
    [No Abstract]   [Full Text] [Related]  

  • 12. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
    Cavusoglu Y; Mert U; Nadir A; Mutlu F; Morrad B; Ulus T
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):603-9. PubMed ID: 24922198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine in Severe Aortic Stenosis with Poor Left Ventricular Ejection Fraction.
    Huang D; Chan PH; Lam CC; Shea PC; Yiu KH; Tse HF; Siu CW
    J Heart Valve Dis; 2015 Jul; 24(4):433-5. PubMed ID: 26897811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
    Bagriy AE; Schukina EV; Samoilova OV; Pricolota OA; Malovichko SI; Pricolota AV; Bagriy EA
    Adv Ther; 2015 Feb; 32(2):108-19. PubMed ID: 25700807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
    Tavazzi L; Swedberg K; Komajda M; Böhm M; Borer JS; Lainscak M; Robertson M; Ford I;
    Int J Cardiol; 2013 Dec; 170(2):182-8. PubMed ID: 24225201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is ivabradine suitable to control undesirable tachycardia induced by dobutamine in cardiogenic shock treatment?
    Roubille F; Lattuca B; Busseuil D; Leclercq F; Davy JM; Rhéaume E; Tardif JC
    Med Hypotheses; 2013 Aug; 81(2):202-6. PubMed ID: 23719030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
    Bakkehaug JP; Naesheim T; Torgersen Engstad E; Kildal AB; Myrmel T; How OJ
    Acta Physiol (Oxf); 2016 Oct; 218(2):78-88. PubMed ID: 27145482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correction of sinus rate by inhibitors of If-channels in patients with acute decompensated heart failure].
    Saĭganov SA; Karchik'ian PO
    Kardiologiia; 2014; 54(11):34-8. PubMed ID: 25902657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivabradine added to guidelines-based therapy in systolic heart failure patients.
    Rusconi AM; Ceriani E;
    Intern Emerg Med; 2011 Jun; 6(3):259-60. PubMed ID: 21573990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.